- Home
- GROW vs LSTA Comparison
GROW vs LSTA Comparison
Compare GROW & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- LSTA
- Stock Information
- Founded
- GROW 1968
- LSTA 1980
- Country
- GROW United States
- LSTA United States
- Employees
- GROW N/A
- LSTA N/A
- Industry
- GROW Investment Managers
- LSTA Misc Health and Biotechnology Services
- Sector
- GROW Finance
- LSTA Health Care
- Exchange
- GROW Nasdaq
- LSTA Nasdaq
- Market Cap
- GROW 32.9M
- LSTA 20.0M
- IPO Year
- GROW N/A
- LSTA N/A
- Fundamental
- Price
- GROW $2.23
- LSTA $2.32
- Analyst Decision
- GROW
- LSTA Strong Buy
- Analyst Count
- GROW 0
- LSTA 1
- Target Price
- GROW N/A
- LSTA $15.00
- AVG Volume (30 Days)
- GROW 26.7K
- LSTA 17.8K
- Earning Date
- GROW 05-08-2025
- LSTA 05-08-2025
- Dividend Yield
- GROW 4.02%
- LSTA N/A
- EPS Growth
- GROW N/A
- LSTA N/A
- EPS
- GROW 0.04
- LSTA N/A
- Revenue
- GROW $9,421,000.00
- LSTA $1,000,000.00
- Revenue This Year
- GROW N/A
- LSTA N/A
- Revenue Next Year
- GROW N/A
- LSTA N/A
- P/E Ratio
- GROW $60.71
- LSTA N/A
- Revenue Growth
- GROW N/A
- LSTA N/A
- 52 Week Low
- GROW $2.21
- LSTA $2.05
- 52 Week High
- GROW $2.95
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- GROW 16.73
- LSTA 42.12
- Support Level
- GROW $2.27
- LSTA $2.07
- Resistance Level
- GROW $2.35
- LSTA $2.62
- Average True Range (ATR)
- GROW 0.04
- LSTA 0.21
- MACD
- GROW -0.02
- LSTA 0.01
- Stochastic Oscillator
- GROW 5.85
- LSTA 47.37
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.